Viewing Study NCT04091503

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 7:16 PM
Ignite Modification Date: 2026-02-24 @ 3:53 AM
Study NCT ID: NCT04091503
Status: COMPLETED
Last Update Posted: 2023-04-25
First Post: 2019-09-08
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Evaluate the Safety and Effectiveness of Intranasal Administration of Temozolomide in Patients With Glioblastoma
Sponsor: Center Trials & Treatment Europe
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Glioma, Malignant View
None Gliosarcoma View
None Astrocytoma of Brain View
Keywords:

Keywords

Keyword Brief Keyword Text View
None TMZ View
None Temozolomide View
None Intranasal Administration View
None Nasal Spray View
None Intranasal Modified Temozolomide View